Identification of novel C-15 fluoro isosteviol derivatives for GABA-AT inhibition by in silico investigations

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Journal of Molecular Modeling

• Publication date

  2023-02-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00894-023-05479-7PMID 36826597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, characterization, and biological evaluation of some novel ϒ-aminobutyric acid aminotransferase (GABA-AT) inhibitors

  2022cited by this paper
• Molecular dynamics-based insight of VEGFR-2 kinase domain: a combined study of pharmacophore modeling and molecular docking and dynamics

  2022cited by this paper
• ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

  2021cited by this paper
• Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways

  2021cited by this paper
• Prediction of Protein-Ligand Binding Pose and Affinity Using the gREST+FEP Method

  2020cited by this paper
• A Supramolecular Approach to Structure-Based Design with A Focus on Synthons Hierarchy in Ornithine-Derived Ligands: Review, Synthesis, Experimental and in Silico Studies

  2020cited by this paper
• Psychotic Episodes After Vigabatrine Treatment: A Case Report

  2020cited by this paper
• Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic☆

  2020cited by this paper
• Docking with AutoDock4.

  2019cited by this paper
• The Epidemiology of Epilepsy

  2019cited by this paper
• Docking studies of biologically active substances from plant extracts with anticonvulsant activity

  2019cited by this paper
• AutoDock Bias: improving binding mode prediction and virtual screening using known protein-ligand interactions

  2019cited by this paper
• Predicting the Binding of Fatty Acid Amide Hydrolase Inhibitors by Free Energy Perturbation.

  2018cited by this paper
• Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.

  2018cited by this paper
• Alteration of GABAergic neurotransmission in Huntington's disease

  2018cited by this paper
• Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.

  2018cited by this paper
• Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling

  2018cited by this paper
• Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.

  2018cited by this paper
• SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

  2017cited by this paper
• UvA-DARE ( Digital Academic Repository ) Neurotransmitters as food supplements : the effects of GABA on brain and behavior

  2017cited by this paper
• Validation of an HPLC method for direct measurement of steviol equivalents in foods.

  2016cited by this paper
• Bicyclic γ-amino acids as inhibitors of γ-aminobutyrate aminotransferase

  2016cited by this paper
• Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.

  2015cited by this paper
• Stevia rebaudiana Bertoni: health promoting properties and therapeutic applications

  2015cited by this paper
• Advancements in Aminofluorination of Alkenes and Alkynes: Convenient Access to β‐Fluoroamines

  2015cited by this paper
• Computer-Aided Identification of Anticonvulsant Effect of Natural Nonnutritive Sweeteners Stevioside and Rebaudioside A

  2015cited by this paper
• Design and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.

  2015cited by this paper
• Recent developments in computational prediction of HERG blockage.

  2013cited by this paper
• A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians

  2013cited by this paper
• Nutritional and therapeutic values of Stevia rebaudiana: A review

  2013cited by this paper
• Wound healing potential of aqueous crude extract of Stevia rebaudiana in mice

  2013cited by this paper
• Antiepileptic drugs 2012: recent advances and trends.

  2012cited by this paper
• γ-Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation

  2012cited by this paper
• Docking-based virtual screening of Schiff’s bases of GABA: a prospective to novel GABA-AT inhibitors

  2012cited by this paper
• (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.

  2012cited by this paper
• iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis

  2011cited by this paper
• Open Babel: An open chemical toolbox

  2011cited by this paper
• SwissParam: A fast force field generation tool for small organic molecules

  2011cited by this paper
• Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models.

  2010cited by this paper
• Vigabatrin (Sabril), a Gamma-Aminobutyric Acid Transaminase Inhibitor for the Treatment of Two Catastrophic Seizure Disorders

  2010cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions

  2009cited by this paper
• Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase.

  2008cited by this paper
• The role of fluorine in medicinal chemistry

  2007cited by this paper
• Methods and Principles in Medicinal Chemistry

  2007cited by this paper
• Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

  2005cited by this paper
• Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin.

  2004cited by this paper
• Structures of γ-Aminobutyric Acid (GABA) Aminotransferase, a Pyridoxal 5′-Phosphate, and [2Fe-2S] Cluster-containing Enzyme, Complexed with γ-Ethynyl-GABA and with the Antiepilepsy Drug Vigabatrin*

  2003cited by this paper
• Virtual screening and fast automated docking methods.

  2002cited by this paper
• A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase.

  2000cited by this paper
• Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.

  2000cited by this paper
• 2,6-Difluorophenol as a bioisostere of a carboxylic acid: bioisosteric analogues of gamma-aminobutyric acid.

  1999cited by this paper
• 2,6‐Difluorophenol as a Bioisostere of a Carboxylic Acid: Bioisosteric Analogues of γ‐Aminobutyric Acid.

  1999cited by this paper
• Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease.

  1990cited by this paper
• GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease.

  1988cited by this paper

• Identification of key bioactive compounds of medicine-food homologous substances and their multi-target intervention effects in ulcerative colitis treatment.

  2026cites this paper
• Carnosic Acid as a Potent Ag85C Inhibitor Identified Through Integrated Pharmacokinetic Evaluation and Molecular Modeling in Mycobacterium Tuberculosis Drug Discovery

  2025cites this paper
• Unraveling potent Glycyrrhiza glabra flavonoids as AKT1 inhibitors using network pharmacology and machine learning-assisted QSAR

  2025cites this paper
• Exploring Placental Protein-Target Protein Interactions: In Silico and In Vitro Approaches for Osteoarthritis Therapy.

  2025cites this paper
• Fused Thiazolo[2,3‐b]Quinazolinone–Chromone Hybrids: Synthesis, Characterization, In Vitro Antibacterial Activity and In Silico Screening

  2024cites this paper
• In silico investigation of potential phytoconstituents against ligand- and voltage-gated ion channels as antiepileptic agents

  2024cites this paper
• Deciphering the 4′,7‐Dihydroxy‐3′‐Methylflavone from Boerhavia, Agonist/Antagonist Interactions Against 5‐HT2 Receptors using Homology Modeling, Molecular Docking, and Dynamic Simulation Studies

  2024cites this paper
• Investigation of Hydantoin‐Based Drugs Used in the Treatment of Epilepsy Using Quantum Chemical Calculations, Molecular Docking, Molecular Dynamics, ADMET, In Vitro, and Spectroscopic Methods

  2024cites this paper
• Exploring the Novel Anticonvulsant Phytochemicals from Glycyrrhiza glabra: An In Silico Approach

  2023cites this paper
• Computational Profile of Novel Natural Bioactive Inhibitors of NF-κB

  2023cites this paper
• Computational Prole of Novel Natural Bioactive Inhibitors of NF-κ B

  year unknowncites this paper